Three generic drug manufacturers cannot claim damages for an injunction barring the release of cheaper versions of Effexor-XR, even if the injunction was later overturned, pharmaceutical giant Wyeth told a judge on day two of a six-week trial over its blockbuster antidepressant.
Hilton Worldwide — which owns New York’s iconic Waldorf Astoria hotel — has won a bid to block an Australian serviced apartments provider from registering trade marks for the phrase “Waldorf Apartments”.
The High Court has rejected a bid by biopharmaceutical company Samsung Bioepis Australia to challenge a ruling granting Pfizer preliminary discovery for a potential patent infringement case over autoimmune drug Enbrel.
Pharmaceutical giant Wyeth’s has launched an “ambush” at the beginning of a trial after a nine-year long battle against several generic drug makers, alleging infringement of a second patent for its blockbuster Effexor-XR, a judge heard Monday.
A decade-long courtroom battle over a patent for Effexor-XR that delayed the release of cheap versions of the anti-depressant is at the centre of a trial starting Monday in Sydney pitting four generic drug makers against pharmaceutical giant Wyeth.
Kmart CEO Guy Russo gave false assurances that the department store had revamped designs for a line of cargo pants and shorts after being warned that it was infringing on the copyright of workwear brand FXD, a new suit alleges.
Gaming giant Aristocrat Technologies told a court Wednesday that confidential material used by a designer to steal its poker machine idea may yet find its way into the launch version of its rival’s machine, despite assurances to the contrary.
A Federal Court judge has granted Chinese restaurant chain Tim Ho Wan’s bid for a temporary injunction in a dispute over trademark rights assigned through a franchise agreement.
Generic drug giant Actavis Global has reached a settlement with AstraZeneca in a long-running patent dispute over blockbuster cholesterol medicine Crestor that wound its way to the High Court.
A trade mark’s reputation is beside the point in an infringement claim alleging deceptive similarity, the Full Federal Court heard Monday in an appeal of a case involving two of Australia’s biggest meat processing and distribution companies.